On this page
Hereditary spastic paraplegia SPG4
This condition primarily affects the nerves that control leg movement, leading to difficulties with walking and balance. It is the most common form of hereditary spastic paraplegia and typically presents in adulthood.
Overview
Hereditary spastic paraplegia SPG4 (HSP-SPG4) is a genetic disorder that falls under a group of conditions known as hereditary spastic paraplegias. These conditions are characterised by progressive stiffness and weakness in the leg muscles, which worsens over time. HSP-SPG4 is considered the most common type of hereditary spastic paraplegia.
The primary feature of HSP-SPG4 is spasticity, meaning the muscles become stiff and resist movement, particularly in the lower limbs. This can make walking challenging and may lead to frequent falls. While the condition primarily affects leg movement, some individuals may experience other neurological symptoms, though these are generally less common.
Symptoms & clinical features
The main symptoms of HSP-SPG4 typically begin gradually and progress over many years. Individuals often first notice stiffness or weakness in their legs, which can make walking difficult or lead to tripping. This spasticity can cause a characteristic gait where the legs may cross or scuff along the ground.
Other symptoms that may occur include an increased reflex response in the legs, problems with balance, and sometimes sensory disturbances like numbness or tingling. While HSP-SPG4 is considered a 'pure' form of HSP in many cases, meaning symptoms are largely confined to leg spasticity and weakness, some individuals may experience 'complicated' features such as intellectual disability, epilepsy, or problems with speech, though these are less common [PMID:31735474]. The severity and progression of symptoms can vary significantly between individuals.
Video: Genetics 101
Affected organs
HSP-SPG4 primarily affects the nervous system, specifically the long nerve fibres (axons) in the spinal cord that control voluntary movement of the legs. These nerve fibres, known as the corticospinal tracts, degenerate over time. This degeneration is responsible for the progressive weakness and spasticity observed in the lower limbs.
While the main impact is on the spinal cord's motor pathways, in some instances, other parts of the brain or peripheral nerves may be affected, leading to a broader range of neurological symptoms. However, the hallmark of HSP-SPG4 remains the progressive dysfunction of these specific spinal cord pathways.
Risks & severity
The severity of HSP-SPG4 can vary widely, even within the same family. Some individuals may experience mild symptoms that only slightly affect their mobility, while others may have more significant walking difficulties requiring mobility aids like canes, walkers, or wheelchairs later in life [PMID:20301707]. The age at which symptoms begin also varies, with onset typically occurring in adulthood, though it can range from childhood to older age.
Progression of the condition is generally slow and gradual. While HSP-SPG4 leads to progressive physical disability, it typically does not affect life expectancy. The condition's impact on daily life depends on the severity of spasticity and weakness, which can influence activities such as walking, climbing stairs, and maintaining balance.
Genetic causes
Hereditary spastic paraplegia SPG4 is caused by pathogenic variants in the SPAST gene. This gene provides instructions for making a protein called spastin. Spastin is important for many cellular processes, particularly those involving microtubules, which are essential components of the cell's internal scaffolding (cytoskeleton).
Microtubules play a critical role in the transport of materials within nerve cells, especially along the long axons. Pathogenic variants in SPAST can disrupt the normal function of spastin, leading to problems with microtubule dynamics and axonal transport. This disruption is thought to contribute to the degeneration of the long nerve fibres in the spinal cord, which in turn causes the characteristic symptoms of HSP-SPG4 [PMID:20301707].
Inheritance pattern
HSP-SPG4 is inherited in an autosomal dominant pattern. This means that only one copy of the altered SPAST gene in each cell is sufficient to cause the condition. An affected individual has a 50% chance of passing on the altered gene, and therefore the condition, to each of their children, regardless of the child's sex.
This inheritance pattern means that the condition can often be seen in multiple generations of a family. Individuals who do not inherit the altered gene will not develop the condition and cannot pass it on to their own children. Genetic counselling can provide detailed information about inheritance risks for affected individuals and their families.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
The diagnosis of HSP-SPG4 often begins with a clinical evaluation by a neurologist, who will assess symptoms such as leg spasticity, weakness, and altered reflexes. Family history is also an important part of the diagnostic process, given the hereditary nature of the condition.
Confirmation of HSP-SPG4 relies on genetic testing to identify pathogenic variants in the SPAST gene. In the UK, genetic testing for hereditary spastic paraplegia is available through the NHS Genomic Medicine Service. A clinician, typically a neurologist or a clinical geneticist, would refer a patient for such testing. The relevant NHS R-codes for genetic testing for hereditary spastic paraplegia would be used to guide the diagnostic pathway.
Management & lifestyle
While there is currently no cure for HSP-SPG4, management focuses on alleviating symptoms and improving quality of life. Physiotherapy is a cornerstone of management, helping to maintain muscle strength, flexibility, and balance, as well as to manage spasticity. Occupational therapy can also be beneficial in adapting daily activities to maintain independence.
Medications may be prescribed to help reduce muscle spasticity, such as baclofen or tizanidine. In some cases, botulinum toxin injections might be used to target specific muscle groups with severe spasticity. Regular follow-up with a neurologist is important to monitor disease progression and adjust management strategies as needed. Lifestyle considerations, such as regular gentle exercise and maintaining a healthy weight, can also contribute to overall well-being.
UK care pathway
In the UK, individuals suspected of having a hereditary neurological condition like HSP-SPG4 would typically be referred to a neurologist for initial assessment. If a genetic cause is suspected, referral to a clinical genetics service would follow. Genetic counsellors play a vital role, providing information about the condition, inheritance patterns, and supporting families through genetic testing decisions.
The NHS Genomic Medicine Service provides comprehensive genomic testing, guided by national testing directories and specific R-codes for conditions like hereditary spastic paraplegias. This ensures that patients receive appropriate and high-quality diagnostic services.
Frequently asked questions
Will I definitely pass HSP-SPG4 on to my children?
HSP-SPG4 is inherited in an autosomal dominant pattern. This means that if you have the condition, there is a 50% chance for each child you have to inherit the altered gene and develop the condition. This chance is the same for every pregnancy.
How quickly will my symptoms get worse?
The progression of HSP-SPG4 is generally slow and gradual, often over many years. The rate of progression and the severity of symptoms can vary greatly between individuals, even within the same family.
Are there any treatments to stop HSP-SPG4 from progressing?
Currently, there is no treatment that can stop the progression of HSP-SPG4. Management focuses on relieving symptoms, such as physiotherapy to manage spasticity and maintain mobility, and medications to reduce muscle stiffness.
Will I eventually need a wheelchair?
The need for a wheelchair varies significantly among individuals with HSP-SPG4. Some people may experience mild symptoms throughout their lives, while others may eventually require mobility aids, including wheelchairs, as the condition progresses. This depends on the severity of spasticity and weakness.
Can HSP-SPG4 affect my brain or other parts of my body?
HSP-SPG4 primarily affects the nerves controlling leg movement. While some individuals may experience additional neurological symptoms like balance issues, or rarely, more complex features, it generally does not affect cognitive function or other major organ systems. It is primarily a disorder of the spinal cord's long nerve fibres.